GYNECOLOGY: OPERATIVE GYNECOLOGYClinical and Patient Reported Outcomes Pre- and Postsurgical Treatment of Symptomatic Uterine Leiomyomas: A12-Month Follow-up Review of TRUST, a Surgical Randomized Clinical Trial Comparing Laparoscopic Radiofrequency Ablation (LAP-RFA) and MyomectomyYu, Steve; Bhagavath, Bala; Shobeiri, S. Abbas; Eisenstein, David; Levy, Barbara Author Information UCLA Health, Los Angeles, CA (S.Y.); University of Wisconsin-Madison, Madison, WI (B.B.); INOVA Women's Hospital, Falls Church, VA (S.A.S.); IHA Obstetrics & Gynecology Rochester Hills, Rochester Hills, MI (D.E.); George Washington University School of Medicine and Health Sciences, Washington, DC (B.L.); and University of California San Diego School of Medicine, San Diego, CA (B.L.) Obstetrical & Gynecological Survey: May 2022 - Volume 77 - Issue 5 - p 266-267 doi: 10.1097/OGX.0000000000001031 Buy Metrics Abstract (Abstracted from J Minim Invasive Gynecol 2022; doi: 10.1016/j.jmig.2022.01.009) Uterine leiomyomas (ULs) affect a large population of women in the United States. Despite the high incidence of women with symptomatic ULs, the number of surgical procedures performed annually is fewer than 250,000. Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.